Journals / Epilepsi / 2002 / Cilt: 8 - Sayı: 2

The effect of valpronic acid and carbamazepine on serum lipid profiles

Valproik asit ve karbamazepinin serum lipid profillerine etkisi

Journal
Epilepsi
Pages
94–98
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings show that neither CPZ nor VPA have significant effects on serum lipid profiles in epileptic patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We investigated the serum lipid profile in epileptic patients receiving carbamazepine or valproic acid.
📊
Key Findings & Data:Patients and Methods: The study included 62 epileptic patients who had been receiving antiepileptic drugs for at least a year without a history of any other disease or drug intake that might affect the serum lipid profile.
💡
Conclusion & Impact:Conclusion: Our findings show that neither CPZ nor VPA have significant effects on serum lipid profiles in epileptic patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antikonvülzanlar · Karbamazepin · Kolesterol

Abstract

Objectives: We investigated the serum lipid profile in epileptic patients receiving carbamazepine or valproic acid. Patients and Methods: The study included 62 epileptic patients who had been receiving antiepileptic drugs for at least a year without a history of any other disease or drug intake that might affect the serum lipid profile. Thirty-four patients (24 females, 10 males; mean age 24 years) were on carbamazepine and 28 patients (20 females, 8 males; mean age 26 years) were on valproic acid treatment. A control group of 30 age- and sex-matched subjects were also included. Serum levels of total cholesterol (TC), high-density-lipoprotein cholesterol (HDL-C), low-density-lipoprotein cholesterol (LDL-C), very low-density-lipoprotein cholesterol (VLDL-C), and triglycéride (TG) were measured and LDL-C/HDL-C and TC/HDL-C ratios were examined. Serum levels of carbamazepine and valproic acid were evaluated in epileptic patients. Results: Serum lipid profiles did not differ signifiicantly in patients treated with carbamazepine and valproic acid when compared with control subjects (p>0.05). No significant differences were found in serum lipids between patients treated with carbamazepine and valproic acid (p>0.05). Conclusion: Our findings show that neither CPZ nor VPA have significant effects on serum lipid profiles in epileptic patients.

Özet

Amaç: Karbamazepin ya da valproik asit kullanmakta olan epilepsili hastalarda kan lipid profillerindeki değişiklikler araştırıldı. Hastalar ve Yöntemler: Çalışmaya en az bir yıldır antiepileptik tedavi gören ve kan lipid profilini etkileyecek hastalığı ya da ilaç kullanım öyküsü olmayan epilepsili 62 hasta alındı. Olguların 34'ü (24 kadın, 10 erkek; ört. yaş 24) valproik asit, 28'i (20 kadın, 8 erkek; ort. yaş 26) karbamazepin ile tedavi görmekteydi. Hasta grubuyla benzer yaş ve cinsiyet özellikleri taşıyan 30 kişilik bir kontrol grubu oluşturuldu. Çalışma ve kontrol gruplarında, kan total kolesterol (TC), yüksek yoğunluklu lipoprotein kolesterol (HDL-C), düşük yoğunluklu lipoprotein kolesterol (LDL-C), çok düşük yoğunluklu lipoprotein kolesterol (VLDL-C) ve trigliserid (TG) düzeyleri ölçüldü; LDL-C/HDL-C ve TC/HDL-C oranları incelendi; ayrıca epilepsili hastalarda valproik asit ve karbamazepin serum düzeyleri araştırıldı. Bulgular: Lipid profilleri açısından valproik asit ile kontrol grubu ve karbamazepin ile kontrol grubu arasında anlamlı fark gözlenmedi (p>0.05). Valproik asit ve karbamazepin kullanan hastaların lipid profilleri karşılaştırıldığında da anlamlı fark saptanmadı (p>0.05). Sonuç: Bulgularımız, karbamazepin ve valproik asidin lipid profili üzerine anlamlı düzeyde olumlu ya da olumsuz bir etkisinin olmadığını gösterdi.

🔖

Cite This Article

YILDIZ, H., EMRE, U., COŞKUN, Ö., GÖNÜLAL, B., İNAN, L. E. (2002). The effect of valpronic acid and carbamazepine on serum lipid profiles. Epilepsi, Cilt: 8 - Sayı: 2, 94–98. https://ajindex.com/articles/167005

References (14)

  1. Livingstone S. Phenytoin and serum cholesterol [Letter]. BMJ 1976;1:586
  2. Onat A, Surdum Avcı G, Şenocak M, Örnek E, İşler M, Özışık U, ve ark. Türkiye'de erişkinlerde kalp hastalığı ve risk faktörleri sıklığı taraması: 4. Kanda kolesterol ve trigliserit düzeyleri. Türk Kardiyoloji Dern Arş 1991;19:16-88
  3. Onat A, Dursunoğlu D, Kahraman G, Ökçün B,Dönmez K, Keleş İ, ve ark. Türk erişkinlerinde ölüm ve koroner olaylar: TEKHARF çalışması kohortu- nun 5 yıllık takibi. Türk Kardiyoloji Dern Arş 1996;24:8-15
  4. Eiris J, Növb-Rodriguez MI, Del Rio M, Meseguer R Del Rio MC, Castro-Gago M. The effects on lipid and apolipoprotein serum levels of long-term carba-mazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res 2000;41:l-7
  5. Muuronen A, Kaste M, Nikkila EA, Tolppanen EM.Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study. Br Med J (Clin Res Ed) 1985;291:1481-3
  6. Eiris JM, Lojo S, Del Rio MC, Novo I, Bravo M,Pavon P, et al. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 1995;45:1155-7
  7. Yıllıkoğlu Y, Sönmez A. Epilepsi. Ankara: Türkiye Klinikleri Yayınevi; 1982. s. 54-8
  8. Faught E, Morris G, Jacobson M, French J, Harden C, Montouris G, et al. Adding lamotrigine to valproate: incidence of rash and other adverse effects.Postmarketing Antiepileptic Drug Survey (PADS) Group. Epilepsia 1999;40:1135-40
  9. Newman WP 3rd, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study.N Engl J Med 1986; 314:138-44
  10. Laurence DR, Bennett PN (editors). Clinical pharmacology. 6th ed. Edinburg: Livingstone; 1996
  11. Cortner JA, Coates PM, Tershakovec AM. Disorders of lipoprotein metabolism and transport. In: Nelson WA, editor. Textbook of pediatrics. 14th ed. Philadelphia: WB Saunders; 1992. p. 359-69
  12. Çetinkaya F, Uysal S, Gürses N. The effects of anticonvulsive drugs on plasma lipids and lipoproteins in epileptic children. Doğa Tr J Medical Sciences 1993;19:31-4
  13. Franzoni E, Govoni M, D'Addato S, Gualandi S,Sangiorgi Z, Descovich GC, et al. Total cholesterol,high-density lipoprotein cholesterol, and triglyc- erides in children receiving antiepileptic drugs.Epilepsia 1992;33:932-5
  14. Luoma PV, Myllyla VV, Hokkanen E. Relationship between plasma high-density lipoprotein cho